tirzepatide risk of cancer Key Takeaways Patients taking GLP-1 receptor agonists for weight loss had a 41% lower obesity-associated cancers compared with patients prescribed diet or exercise. Patients taking had substantially greater Does Tirzepatide Cause Cancer?

With a delicious blend of mild spices and creamy avocado, this salad is perfect for a quick and easy lunch or dinner

Their work was recently recognized by the university's Technology Licensing Office, which named them 2025 Founders of the Year for developing the PolyMacrocyclic Peptide (pMCP) Discovery Platform

Other medications were allowed other than GLP-1 RAs

If youve ever found yourself absentmindedly humming the oh-oh-oh-Ozempic jingle, you have David Paton to blame

NAFLD is a common condition in obese patients, and investigators hypothesize that tesamorelin may reduce liver fat and improve liver scarring and inflammation in this disease 4